Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Bioscience entities : Meridian bioscience inc. save search
Global Enteric Disease Testing Market Report to 2027 - Players Include Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience and Quest Diagnostics
Published: 2023-02-02 (Crawled : 23:00) - prnewswire.com
DHR | $236.08 0.24% 0.0% 2.8M
|
Health Technology
|
| O: -0.71%
H: 0.94%
C: 0.41%
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: -0.39%
H: 0.46%
C: -0.02%
global disease report diagnostics bioscience market
SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience
Published: 2023-01-31 (Crawled : 20:00) - prnewswire.com
VIVO | $33.97 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
acquire bioscience
Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger
Published: 2022-12-12 (Crawled : 13:20) - prnewswire.com
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 6.82%
H: 0.33%
C: -0.45%
bioscience
MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2022 OPERATING RESULTS
Published: 2022-11-22 (Crawled : 14:20) - biospace.com/
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
year bioscience results
MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS
Published: 2022-08-05 (Crawled : 12:00) - prnewswire.com
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: -2.35%
H: 0.0%
C: 0.0%
bioscience results
Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular Assay
Published: 2022-07-29 (Crawled : 14:00) - prnewswire.com
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: -0.19%
H: 0.31%
C: -0.78%
revogene fda sars-cov-2 bioscience molecular
Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter
Published: 2022-07-07 (Crawled : 12:00) - biospace.com/
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 5.19%
H: 0.0%
C: 0.0%
bioscience
Meridian Bioscience responds to the Monkeypox Outbreak with its Inhibitor-Tolerant qPCR Master Mixes for the Development of Molecular Tests
Published: 2022-05-26 (Crawled : 18:00) - prnewswire.com
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 0.74%
H: 3.93%
C: 1.31%
monkeypox bioscience molecular test
Meridian Bioscience Launches Lyo-Ready™ Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic Assays
Published: 2022-05-17 (Crawled : 21:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -1.28%
H: 6.22%
C: 3.63%
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 1.5%
H: 1.68%
C: 1.48%
care dna diagnostic bioscience
Meridian Bioscience Launches Lyo-Ready™ Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic Assays
Published: 2022-05-17 (Crawled : 20:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -4.22%
H: 6.49%
C: -1.86%
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: -1.81%
H: 2.05%
C: 1.53%
care dna diagnostic bioscience
Meridian Bioscience Announces Preliminary Net Revenues Results for Fiscal 2022 Second Quarter
Published: 2022-04-07 (Crawled : 13:00) - biospace.com/
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 1.26%
H: 5.58%
C: 5.09%
bioscience results
Meridian Bioscience Launches Lyo-Ready™ qPCR Inhibitor Tolerant Blood-Specific Master Mixes for DNA & RNA Direct Detection
Published: 2022-03-29 (Crawled : 19:00) - biospace.com/
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 0.39%
H: 2.61%
C: 1.85%
bioscience
Meridian Bioscience Launches Lyo-Ready™ qPCR Inhibitor Tolerant Blood-Specific Master Mixes for DNA & RNA Direct Detection
Published: 2022-03-29 (Crawled : 19:00) - prnewswire.com
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 0.04%
H: 3.58%
C: -0.64%
bioscience
Meridian Bioscience Names Andy Kitzmiller as Chief Financial Officer
Published: 2022-02-21 (Crawled : 14:30) - prnewswire.com
VIVO | $33.97 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
bioscience
MERIDIAN BIOSCIENCE REPORTS SECOND BEST QUARTER IN COMPANY HISTORY
Published: 2022-02-04 (Crawled : 14:00) - biospace.com/
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
report bioscience
Meridian Bioscience Receives Additional NIH Award to Support the Rapid Development of the Revogene® Molecular Viral Respiratory Testing Panel
Published: 2022-01-31 (Crawled : 17:00) - prnewswire.com
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 0.55%
H: 1.24%
C: -4.23%
revogene respiratory test bioscience molecular
Meridian Bioscience Launches Lyo-Ready™ qPCR Saliva-Specific Master Mixes for DNA & RNA Direct Detection
Published: 2022-01-28 (Crawled : 19:00) - biospace.com/
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 0.0%
H: 4.84%
C: 4.74%
saliva bioscience
Meridian Bioscience Launches Lyo-Ready™ qPCR Saliva-Specific Master Mixes for DNA & RNA Direct Detection
Published: 2022-01-28 (Crawled : 15:30) - prnewswire.com
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 0.0%
H: 4.84%
C: 4.74%
saliva bioscience
Meridian Bioscience Elects John C. McIlwraith New Chairman of the Board
Published: 2022-01-27 (Crawled : 20:00) - biospace.com/
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 0.63%
H: 1.53%
C: -1.01%
air bioscience
Meridian Bioscience Receives FDA-Clearance for the Curian® Campy Assay
Published: 2022-01-05 (Crawled : 15:30) - prnewswire.com
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: -0.39%
H: 2.16%
C: -0.39%
curian fda clearance bioscience fda clearance
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.